BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 18562427)

  • 41. Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.
    Tanay VM; Greenshaw AJ; Baker GB; Bateson AN
    Mol Psychiatry; 2001 Jul; 6(4):404-12. PubMed ID: 11443524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.
    Zwanzger P; Rupprecht R
    J Psychiatry Neurosci; 2005 May; 30(3):167-75. PubMed ID: 15944741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case report of alprazolam-induced stuttering.
    Elliott RL; Thomas BJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin regulation of the human stress response.
    Hood SD; Hince DA; Robinson H; Cirillo M; Christmas D; Kaye JM
    Psychoneuroendocrinology; 2006 Oct; 31(9):1087-97. PubMed ID: 16962720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
    Sanderson WC; Wetzler S; Asnis GM
    Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.
    Barbee JG
    J Clin Psychiatry; 1993 Oct; 54 Suppl():86-97; discussion 98-101. PubMed ID: 8262893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
    Roy-Byrne PP; Cowley DS; Hommer D; Greenblatt DJ; Kramer GL; Petty F
    Psychopharmacology (Berl); 1992; 109(1-2):153-6. PubMed ID: 1365649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 35% carbon dioxide reactivity between panic disorder and eating disorder.
    Perna G; Casolari A; Bussi R; Cucchi M; Arancio C; Bellodi L
    Psychiatry Res; 2004 Mar; 125(3):277-83. PubMed ID: 15051188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growing placebo response rate: the problem in recent therapeutic trials?
    Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
    Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of experimental panic on neuroimmunological functioning.
    van Duinen MA; Schruers KR; Kenis GR; Wauters A; Delanghe J; Griez EJ; Maes MH
    J Psychosom Res; 2008 Mar; 64(3):305-10. PubMed ID: 18291246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects.
    Poma SZ; Milleri S; Squassante L; Nucci G; Bani M; Perini GI; Merlo-Pich E
    J Psychopharmacol; 2005 Sep; 19(5):494-503. PubMed ID: 16166187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.